Bio-Techne, Merck KGaA
Digest more
Shares of U.S. life sciences company Bio-Techne jumped more than +22% in premarket trading on Thursday after Merck KGaA agreed to acquire the company for $73 per share in cash, va ...
Activist investor Ananym Capital Management has built a stake in Bio-Techne Corp. and is pushing the board to conduct a ...
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Bio-Techne Corporation (NASDAQ: TECH) to Merck ...
(TECH) was up 20.9% in pre-market trading, and Micron Technology Inc. (MU) was up 17.7%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results